Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930969 · ClinicalTrials.gov registry record
ST Segment Detection Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- 175
- Enrollment target
NCT00930969 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 175 participants.
The verdict
NCT00930969 was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- 175 participants
- Enrollment target
Study Summary
The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) who have coronary artery disease.
Interventions
- DEVICE ICD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00930969
The ClinicalTrials.gov registry entry for NCT00930969 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ICD is the first listed.
NCT00930969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00930969 about?
NCT00930969 is a clinical study titled "ST Segment Detection Study". The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) wh...
What is the current status of trial NCT00930969?
This trial is currently terminated. The enrollment target is 175 participants. The study started on 2008-04. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00930969?
The interventions under investigation include: ICD (DEVICE).
Who is sponsoring clinical trial NCT00930969?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.